systhiperСистемные гипертензииSystemic Hypertension2075-082X2542-2189LLC «ИнтерМедсервис»systhiper-711Research ArticleСТАТЬИARTICLESДинамика уровня артериального давления по данным клинического измерения и суточного мониторирования у больных старше 75 лет на фоне монотерапии индапамидом ретардКобалаваЖ. Д.noemail@neicon.ruМарковаМ. А.noemail@neicon.ruРоссийский университет дружбы народов на базе ГКБ №64, МоскваRussian Federation201109022023841115Copyright © Кобалава Ж.Д., Маркова М.А., 20232023Кобалава Ж.Д., Маркова М.А.Кобалава Ж.Д., Маркова М.А.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.syst-hypertension.ru/jour/article/view/711ReferencesFagard RH. Epidemiology of hypertension in the elderly. Am J Geriatr Cardiol 2002; 11: 24-7.Fagard RH. Epidemiology of hypertension in the elderly. Am J Geriatr Cardiol 2002; 11: 24-7.Шальнова С.А., Деев А.Д., Вихирева О.В. и др. Распространенность артериальной гипертонии в России: информированность, лечение, контроль. Профилактика заболеваний и укрепление здоровья. 2001; 2: 3-7.Шальнова С.А., Деев А.Д., Вихирева О.В. и др. Распространенность артериальной гипертонии в России: информированность, лечение, контроль. Профилактика заболеваний и укрепление здоровья. 2001; 2: 3-7.Lewington S, Clarke R, Qizilbash N et al. Age-specific relevance of usual blood pressure to vascular mortality. Lancet 2002; 360: 1903-13.Lewington S, Clarke R, Qizilbash N et al. Age-specific relevance of usual blood pressure to vascular mortality. Lancet 2002; 360: 1903-13.Beckett N, Peters R, Fletcher A et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-98.Beckett N, Peters R, Fletcher A et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-98.Oates D, Berlowitz D, Glickman M et al. Blood pressure and survival in the oldest old. J Am Geriart Soc 2007; 55: 383-8.Oates D, Berlowitz D, Glickman M et al. Blood pressure and survival in the oldest old. J Am Geriart Soc 2007; 55: 383-8.Satish S, Freeman D, Ray L, Goodwin J. The relationship between blood pressure and mortality in the oldest old. J Am Geriart Soc 2001; 49 (4): 367-4.Satish S, Freeman D, Ray L, Goodwin J. The relationship between blood pressure and mortality in the oldest old. J Am Geriart Soc 2001; 49 (4): 367-4.Madhavan S, Ooi WL, Cohen H, Alderman M. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994; 23: 395-401.Madhavan S, Ooi WL, Cohen H, Alderman M. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994; 23: 395-401.Bulpitt CJ, Beckett NS, Cooke J et al. Hypertension in the Very Elderly Trial Working Group. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 2003; 21: 2409-17. Abstract.Bulpitt CJ, Beckett NS, Cooke J et al. Hypertension in the Very Elderly Trial Working Group. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 2003; 21: 2409-17. Abstract.Bulpitt CJ, Fletcher AE, Amery A et al. The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials. Drugs Aging 1994; 5: 171-83. Abstract.Bulpitt CJ, Fletcher AE, Amery A et al. The Hypertension in the Very Elderly Trial (HYVET). Rationale, methodology and comparison with previous trials. Drugs Aging 1994; 5: 171-83. Abstract.Ferrucci L, Furberg C, Pennix B et al. Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation 2001; 104: 1923-6.Ferrucci L, Furberg C, Pennix B et al. Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation 2001; 104: 1923-6.MRC Working party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMG 1992; 304: 405-12.MRC Working party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMG 1992; 304: 405-12.Coope J, Warrender T. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ (Clin Res Ed) 1986; 293: 1145-51.Coope J, Warrender T. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ (Clin Res Ed) 1986; 293: 1145-51.Amery A, Birkenhager W, Brixko P et al. Mortality and morbidity results from the European Working party on High Blood Pressure in the Elderly trial. Lancet 1985; 1: 1349-54.Amery A, Birkenhager W, Brixko P et al. Mortality and morbidity results from the European Working party on High Blood Pressure in the Elderly trial. Lancet 1985; 1: 1349-54.Dahlof B, Lindholm LH, Hansson L et al. Morbidity and mortality in the Swedish Trial in the Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-5.Dahlof B, Lindholm LH, Hansson L et al. Morbidity and mortality in the Swedish Trial in the Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-5.Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).J Hypertens 2007; 25: 1105-87.Mancia G, De Backer G, Dominiczak A et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).J Hypertens 2007; 25: 1105-87.Национальные клинические рекомендации. Сборник под ред. Р.Г.Органова. 3-е издание. М., 2010; с. 487.Национальные клинические рекомендации. Сборник под ред. Р.Г.Органова. 3-е издание. М., 2010; с. 487.Кобалава Ж.Д., Котовская Ю.В., Верещагина Г.Н. и др. Переносимость и эффективность ретардной формы индапамида в лечении гипертонии у пожилых людей. Кардиология. 2002; 42 (7): 25-35.Кобалава Ж.Д., Котовская Ю.В., Верещагина Г.Н. и др. Переносимость и эффективность ретардной формы индапамида в лечении гипертонии у пожилых людей. Кардиология. 2002; 42 (7): 25-35.Моисеев В.С. Артериальная гипертония у пожилых. Клин. фармакология и терапия. 2006; 4: 20-3.Моисеев В.С. Артериальная гипертония у пожилых. Клин. фармакология и терапия. 2006; 4: 20-3.Bataillard A, Schiavi P, Sassard J. Pharmacological properties of indapamide. Clin Pharmacokinet 1999; 37 (Suppl. 1): 7-12.Bataillard A, Schiavi P, Sassard J. Pharmacological properties of indapamide. Clin Pharmacokinet 1999; 37 (Suppl. 1): 7-12.Моисеев B.C. Лекарство и качество жизни. Клин. фармакол. и тер. 1993; 1: 33-5.Моисеев B.C. Лекарство и качество жизни. Клин. фармакол. и тер. 1993; 1: 33-5.Моисеев В.С., Кобалава Ж.Д. АРГУС Артериальная гипертония у лиц старших возрастных групп. М.: МИА, 2002; с. 446.Моисеев В.С., Кобалава Ж.Д. АРГУС Артериальная гипертония у лиц старших возрастных групп. М.: МИА, 2002; с. 446.Carmona J, Vasconcelos N, Amado P et al. Blood pressure morning rise profile in hypertensive patients and controls evaluated by ambulatory blood pressure monitoring. Abstracts of VH-th European meeling on hypertension 1992; 33.Carmona J, Vasconcelos N, Amado P et al. Blood pressure morning rise profile in hypertensive patients and controls evaluated by ambulatory blood pressure monitoring. Abstracts of VH-th European meeling on hypertension 1992; 33.
The authors declare that there are no conflicts of interest present.